{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"TechDaily.ai","title":"AI × Biotech Revolution: How Genomics, CRISPR & Machine Learning Are Accelerating Drug Discovery","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/1972d5bc\"></iframe>","width":"100%","height":180,"duration":1078,"description":"Discover how AI and biotech are joining forces to transform drug development—from genomics and CRISPR target validation to machine learning–driven compound design and high-throughput screening. In this episode of TechDaily.AI (brought to you by StoneFly), we cover:Omics Insights: Mining genomics, transcriptomics, proteomics & metabolomics to pinpoint targetsGene Editing: Using CRISPR and CAR-T engineering for precision therapiesAI in Drug Design: Leveraging ML/DL for toxicity prediction, ADME modeling & de novo molecule generationAutomation & Scale: High-throughput assays, synthetic biology platforms (e.g., engineered yeast)Clinical Acceleration: AI-powered patient matching for faster trialsRoadmap & Challenges: Data quality, explainable AI, vendor collaboration & regulatory readinessTune in to learn how this synergy is cutting R&D costs, speeding timelines, and paving the way for personalized medicine.","thumbnail_url":"https://img.transistorcdn.com/MKzoODnpsE2Vy4aGphW9b-GBzDjrXS02jU9UfoOrOl4/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9mZjQ4/NzM0YWU5MjE5MmI4/NzM3Mjg2YzM0NGE5/ZjUzYi5wbmc.webp","thumbnail_width":300,"thumbnail_height":300}